31 related articles for article (PubMed ID: 34044271)
21. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate.
Cui J; Hollmén M; Li L; Chen Y; Proulx ST; Reker D; Schneider G; Detmar M
Oncotarget; 2017 Jan; 8(1):1007-1022. PubMed ID: 27894093
[TBL] [Abstract][Full Text] [Related]
22. Targeted destruction of cancer stem cells using multifunctional magnetic nanoparticles that enable combined hyperthermia and chemotherapy.
Liu D; Hong Y; Li Y; Hu C; Yip TC; Yu WK; Zhu Y; Fong CC; Wang W; Au SK; Wang S; Yang M
Theranostics; 2020; 10(3):1181-1196. PubMed ID: 31938059
[TBL] [Abstract][Full Text] [Related]
23. A high-throughput screen identifies inhibitors of lung cancer stem cells.
She X; Gao Y; Zhao Y; Yin Y; Dong Z
Biomed Pharmacother; 2021 Aug; 140():111748. PubMed ID: 34044271
[TBL] [Abstract][Full Text] [Related]
24. Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds.
Maiuthed A; Chantarawong W; Chanvorachote P
Anticancer Res; 2018 Jul; 38(7):3797-3809. PubMed ID: 29970499
[TBL] [Abstract][Full Text] [Related]
25. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
26. Lung cancer stem cells: tumor biology and clinical implications.
Nurwidya F; Murakami A; Takahashi F; Takahashi K
Asia Pac J Clin Oncol; 2012 Sep; 8(3):217-22. PubMed ID: 22897822
[TBL] [Abstract][Full Text] [Related]
27. Emerging agents that target signaling pathways in cancer stem cells.
Yang Y; Li X; Wang T; Guo Q; Xi T; Zheng L
J Hematol Oncol; 2020 May; 13(1):60. PubMed ID: 32456660
[TBL] [Abstract][Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
